Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Diabetes Drug Development: Seeing Light In The Dark Ages?

Feb 27 2012

• By Marc Wortman

Related Content

Obesity Drugs Go Back To The Drawing Board; FDA To Hold Advisory Cmte On CV Risk

Jun 03 2011

Catabasis Pharmaceuticals Inc.

Jun 01 2010

Omthera Pharmaceuticals Inc.

Jan 01 2011

Zafgen Finds Plentiful Funding in Slimmed Down Obesity Market

Oct 01 2008

Phenomix Folds After Diabetes Drug Fails To Attract Partner To Fill Forest's Shoes

Aug 31 2010

FDA Diabetes Guidance Encourages Enrollment Of Sicker Patients

Dec 17 2008

Regulatory Risk and Business Development: Type 2 Diabetes Falls Out of Favor

Oct 01 2008

Related Companies

Forest Laboratories, Inc.

Bristol Myers Squibb Company

Alkermes plc

Thermalin Diabetes LLC

Astria Therapeutics, Inc.

Omthera Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.

Ember Therapeutics, Inc.

Larimar Therapeutics, Inc.

Metabolic Solutions Development Company

Additional Topics

Business Strategies Clinical Trials Deals Innovation BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window